Aquaculture

While shrimp are most severely affected, WSSV also infects a wide range of crustaceans and aquatic species, including crabs and certain fish, leading to significant morbidity, mortality, and productivity loss across farming systems. WSSV exhibits considerable genetic variability among isolates, making it challenging to develop broad-spectrum antiviral strategies such as traditional protease inhibitors. Compounding this challenge, aquatic animals like shrimp and crabs rely solely on innate immunity, offering limited and short-term defense against viral infections.Conventional control measures—particularly oral administration of antiviral agents—are often constrained by low bioavailability, instability in pond or saline environments, and high operational costs.These challenges underscore the need for a cost-effective, thermally stable, and scalable antiviral solution applicable across diverse aquaculture species.PioKil-V has been specifically developed to meet this need, providing a broad-spectrum antiviral approach for the prevention and control of WSSV and related viral infections in shrimp, fish, and crabs.